Outcome MeasureQuality of Life
EQ-5D-3L
EuroQol 5-Dimension 3-Level
1 Paper in Blossom
Clinical Thresholds
Worse than dead
Impaired QoL
Good QoL
-0.591
Worse than dead
Score -1–0
Impaired QoL
Score 0–0
Good QoL
Score 1–1
Outcome Data Across Studies
Reported results for EQ-5D-3L across 1 study with quantitative data.
| SD | ||||||
|---|---|---|---|---|---|---|
| Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication 2023Exploratory | 25 mg COMP360(experimental) | 0 | 19 | 0.5 | 0.3 | — |
| Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication 2023Exploratory | 25 mg COMP360(experimental) | 21 | 19 | 0.2Δ | 0.3 | — |
Papers Using EQ-5D-3L
Quick Facts
- Full Name
- EuroQol 5-Dimension 3-Level
- Domain
- Quality of Life
- Papers Indexed
- 1
- Score Range
- -0.59–1
- Interpretation
- Higher = better
- Unit
- utility index
- Reference
- Visit